Overview

Clinical Trial Ceftriaxone in Subjects With ALS

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of ceftriaxone treatment in amyotrophic lateral sclerosis (ALS).
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Ceftriaxone
Cephalosporins